Cited by 43Metabolism and Genetic DisordersMetabolomics and Mass Spectrometry StudiesPolyamine Metabolism and Applications

N8‐acetylspermidine as a potential plasma biomarker for Snyder‐Robinson syndrome identified by clinical metabolomics

Open access
Abela, Lucia, Simmons, Luke, Steindl, Katharina, Schmitt, Bernhard, Mastrangelo, Massimo, Joset, Pascal, Papuc, Mihaela, Sticht, Heinrich +5 more·2016·Journal of Inherited Metabolic Disease

Abstract

Clinical metabolomics has emerged as a powerful tool to study human metabolism in health and disease. Comparative statistical analysis of untargeted metabolic profiles can reveal perturbations of metabolite levels in diseases and thus has the potential to identify novel biomarkers. Here we have applied a simultaneous genetic-metabolomic approach in twin boys with epileptic encephalopathy of unclear etiology. Clinical exome sequencing identified a novel missense mutation in the spermine synthase gene (SMS) that causes Snyder-Robinson syndrome (SRS). Untargeted plasma metabolome analysis revealed significantly elevated levels of N(8)-acetylspermidine, a precursor derivative of spermine biosynthesis, as a potential novel plasma biomarker for SRS. This result was verified in a third patient with genetically confirmed SRS. This study illustrates the potential of metabolomics as a translational technique to support exome data on a functional and clinical level.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s10545-015-9876-y

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • A study to identify biomarkers for Snyder Robinson syndrome obtained data on 16 patients, only three of which presented with the disorder of interest.

    “For example, a study to identify biomarkers for Snyder Robinson syndrome, a rare neurological disorder, obtained data on 16 patients, only three of which presented with the disorder of interest (Abela et al., 2015).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Arena JF, Schwartz C, Ouzts L et al (1996) X-linked mental retardation with thin habitus, osteoporosis, and kyphoscoliosis: linkage to Xp21.3-p22.12. Am J Med Genet 64(1):50-58
  2. Smith CA, O'Maille G, Want EJ et al (2005) METLIN -Ametabolite mass spectral database. Ther Drug Monit 27(6):747-751

Cited by

Sorted by citations

Authors
Abela, L., Simmons, L., Steindl, K., Schmitt, B., Mastrangelo, M., Joset, P., Papuc, M., Sticht, H., Baumer, A., Crowther, L. M., Mathis, D., Rauch, A., & Plecko, B.
Affiliations
  • University of Zurich (CH)
  • Ospedale dei Bambini Vittore Buzzi (IT)
  • Radiz–Rare Disease Initiative Zurich, Clinical Research Priority Program for Rare Diseases University of Zurich Steinwiesstrasse 75 Zurich 8032 Switzerland
  • Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
  • University Children's Hospital Zurich (CH)
Corresponding author
Plecko, Barbara
Venue
Journal of Inherited Metabolic Disease
Publisher
Wiley
Published
2015-07-15
Volume
39
Issue
1
Pages
131-137
ISSN
  • 0141-8955 (ISSN-L)
  • 1573-2665
OpenAlex
W1580029308
Cited by
43
References
29
Citations by year
2026: 2 · 2025: 2 · 2024: 5 · 2023: 4 · 2022: 6 · 2021: 1 · 2020: 6 · 2019: 3 · 2018: 8 · 2017: 3 · 2016: 3
FWCI
3.86
Type
journal article
Language
en
Open access
Locations
  • Journal of Inherited Metabolic Disease (publishedVersion)
  • PubMed (publishedVersion)
  • Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
  • Zurich Open Repository and Archive (University of Zurich)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolomics and Mass Spectrometry Studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Polyamine Metabolism and Applications
Keywords
Snyder-Robinson syndrome, N8-acetylspermidine, plasma biomarkers, spermine synthase, missense mutations, epileptic encephalopathy
MeSH terms
Adolescent, Child, Child, Preschool, Female, Humans, Infant, Male, Pedigree, Plasma, Spermidine, Spermine Synthase, Biomarkers, Case-Control Studies, Mutation, Missense, X-Linked Intellectual Disability, Metabolomics, Metabolome, Exome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review